PRIMARY STUDY

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

Key Findings:  Although there was no remission, the subjective physician's overall assessment of illness severity, as well as patients subjective reports suggest improvements in quality-of-life outcomes in patients taking CBD-rich botanical extract. Adverse events were mostly mild/moderate with many in the CBD-rich botanical extract group potentially attributable to the ∆9-tetrahydrocannabinol content. suggest CBD-rich botanical extract may be beneficial for symptomatic treatment of UC